Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Derek Tan
Q&A
Monday, September 16, 2013

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

Pictured: Denis Chi
Ask the Expert
Thursday, September 5, 2013

In this “Ask the Expert” feature, gynecologic surgeon Dennis Chi discusses why screening for ovarian cancer is not as widespread as it is for certain other cancers.

Monday, August 12, 2013

Memorial Sloan Kettering’s Resources for Life After Cancer program was created to support cancer survivors in dealing with psychological, physical, and practical issues related to cancer and its treatment.

Pictured: Clostridium difficile
In the Lab
Wednesday, August 7, 2013

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Pictured: Luciano Martelotto, Catherine Cowell & Jorge Reis-Filho
Profile
Monday, August 5, 2013

Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.

Pictured: Philip Gutin
Cancer Guide
Monday, July 15, 2013

Memorial Sloan Kettering’s Brain Tumor Center provides world-class care to people with low-grade glioma, a type of slow-growing brain tumor.

Pictured: Christina Leslie
Profile
Friday, June 28, 2013

Christina Leslie develops computational and statistical methods to study gene expression in normal cells and in cancer cells.

Pictured:  Timothy Chan
In the Lab
Friday, May 24, 2013

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

Pictured: Steven Wang
Ask the Expert
Wednesday, May 15, 2013

In this “Ask the Expert” feature, dermatologist Steven Wang discusses how to choose the most effective sunscreen.

Pictured: Charles Sawyers
In the Lab
Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Gary Schwartz & Mark Dickson
In the Clinic
Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan Kettering’s clinical genetics experts.

Pictured: Virtual Programs
Event
Friday, April 12, 2013

Memorial Sloan Kettering’s Virtual Programs offers patients private, online support and education sessions to participate in from home or work.

Pictured: José Baselga
Finding
Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Kenneth Offit
Finding
Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.